LP441587-5
A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
Active
Basic Part Properties
- Part Name
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
- Part Display Name
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2024-05-27
- Construct for LOINC Short Name
- Not in the expected range of benefit
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Μια μελέτη για τη χημειοθεραπεία μείωσε τον κίνδυνο θανάτου από καρκίνο του παχέος εντέρου κατά περίπου 30% και ήταν 95% βέβαιο ότι το αναμενόμενο εύρος οφέλους κυμαινόταν μεταξύ 10% και 50%. Synonyms: Μια μελέτη για τη χημειοθεραπεία μείωσε τον κίνδυνο θανάτου από καρκίνο του παχέος εντέρου κατά περίπου 30% και ήταν 95% βέβαιο ότι το αναμενόμενο εύρος οφέλους κυμαινόταν μεταξύ 10% και 50%. |
| zh-CN | Chinese (China) | 研究表明化疗将死于结肠癌的风险降低了约 30%， |
| it-IT | Italian (Italy) | Uno studio sulla chemioterapia ha ridotto il rischio di morte per cancro del colon di circa il 30%. ed era certo al 95% che l'intervallo di beneficio atteso fosse tra il 10% e il 50% |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://